Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07600801 · ClinicalTrials.gov registry record
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
A clinical trial, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- 2,250
- Enrollment target
NCT07600801: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT07600801 is a clinical trial that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 2,250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07600801 has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- 2,250 participants
- Enrollment target
Study Summary
This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals with a family history of lung cancer.
Primary Outcome
We will estimate future lung cancer diagnoses using the area under the receiver operating curve (AUROC).
Interventions
- DIAGNOSTIC_TEST CT scan
- OTHER Sybil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,250 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2035-12-31 |
What is known before NCT07600801 opens enrollment
NCT07600801 is an observational study that tracks outcomes without assigning an intervention. Its 2,250 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which CT scan is the first listed.
NCT07600801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07600801 about?
NCT07600801 is a clinical study titled "LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B". This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals with a family history of lung cancer.
What is the current status of trial NCT07600801?
This trial is currently not yet recruiting. The enrollment target is 2,250 participants. The study started on 2026-06-15. Estimated completion is 2035-12-31.
What interventions are being tested in trial NCT07600801?
The interventions under investigation include: CT scan (DIAGNOSTIC_TEST), Sybil (OTHER).
Who is sponsoring clinical trial NCT07600801?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI